BIOS VS CPSS Stock Comparison

PerformanceAnalyst Price TargetsProfitVolatilitySentimentTechnicalsEarnings
PerformanceAnalyst Price TargetsProfitVolatilitySentimentTechnicalsEarnings

Performance

BIOS
100/100

BIOS returned 7.25% in the last 12 months. Based on SPY's performance of -3.02%, its performance is above average giving it a score of 100 of 100.

CPSS
100/100

CPSS returned 24.66% in the last 12 months. Based on SPY's performance of -1.87%, its performance is above average giving it a score of 100 of 100.

Analyst Price Targets

BIOS
88/100

6 analysts offer 12-month price targets for BIOS. Together, they have an average target of 0, the most optimistic target put BIOS at 0 within 12-months and the most pessimistic has BIOS at 0. These analyst ratings are from our partners at Financial Modeling Prep and Alpha Vantage.

CPSS
63/100

4 analysts offer 12-month price targets for CPSS. Together, they have an average target of 0, the most optimistic target put CPSS at 0 within 12-months and the most pessimistic has CPSS at 0.

Profit

BIOS
12/100

Out of the last 20 quarters, BIOS has had 4 profitable quarters and has increased their profits year over year on 0 of them.

CPSS
86/100

Out of the last 20 quarters, CPSS has had 20 profitable quarters and has increased their profits year over year on 10 of them.

Volatility

BIOS
10/100

BIOS has had a lower than average amount of volatility over the last 12 months giving it a score of 10 of 100.

CPSS
53/100

CPSS has had a higher than average amount of volatility over the last 12 months giving it a score of 53 of 100.

Sentiment

BIOS

"Sentiment" not found for BIOS

CPSS
68/100

CPSS had a bullish sentiment score of 67.56% across Twitter and StockTwits over the last 12 months. It had an average of 3.00 posts, 0.00 comments, and 0.00 likes per day.

Technicals

BIOS

"Technicals" not found for BIOS

CPSS
79/100

CPSS receives a 78 of 100 based on 14 indicators. 10 are bullish, 2 are bearish.

Earnings

BIOS

"Earnings" not found for BIOS

CPSS
10/100

CPSS has missed earnings 6 times in the last 20 quarters.

All score calculations are broken down here to help you make more informed investing decisions

BioPlus Acquisition Corp. Class A Ordinary Shares Summary

Nasdaq / BIOS
Financial Services
Shell Companies
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.

Consumer Portfolio Services Summary

Nasdaq / CPSS
Financial Services
Financial - Credit Services
Consumer Portfolio Services, Inc. operates as a specialty finance company in the United States. It is involved in the purchase and service of retail automobile contracts originated by franchised automobile dealers and select independent dealers in the sale of new and used automobiles, light trucks, and passenger vans. The company, through its automobile contract purchases, offers indirect financing to the customers of dealers with limited credit histories or past credit problems. It serves as an alternative source of financing for dealers, facilitating sales to customers who are not able to obtain financing from commercial banks, credit unions, and the captive finance companies. The company also acquires installment purchase contracts in four merger and acquisition transactions; purchases immaterial amounts of vehicle purchase money loans from non-affiliated lenders. and offers financing directly to sub-prime consumers to facilitate their purchase of a new or used automobile, light truck, or passenger van. It services its automobile contracts through its branches in California, Nevada, Virginia, Florida, and Illinois. The company was founded in 1991 and is based in Las Vegas, Nevada.